INFI stock forecast
Our latest prediction for Infinity Pharmaceuticals, Inc.'s stock price was made on the Dec. 13, 2018 when the stock price was at 1.20$.
In the short term (2weeks), INFI's stock price should outperform the market by 6.92%. During that period the price should oscillate between -9.15% and +21.69%.
In the medium term (3months), INFI's stock price should outperform the market by 12.88%. During that period the price should oscillate between -20.06% and +59.32%.Get email alerts
Create a solid portfolio with INFI
About Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
At the moment the company generates 22M USD in revenues.
On its last earning announcement, the company reported a loss of -0.21$ per share.
The book value per share is 0.80$
Three months stock forecastDec. 13, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|